Rare Disease Lead Generation

TrialCard’s Lead Generation product is well suited to the growing orphan drug market. Specialty representatives, trained on the science of a particular therapy, use talking points and probing questions in calls with target offices to uncover potential patients that may benefit from orphan therapies.

The impact of a TrialCard program, on a scale of 1 to 10.

Bar graph showing the impact of a TrialCard program, on a scale of 1 to 10.

*Info from a recent client survey

A photo of a young boy in the background superimposed with a calendar with days marked off in red X's.

Metrics

Rare disease Virtual Specialty Representatives program (2 FTE 6-Month Model)

  • Delivered 10 times more leads than forecasted

  • Virtual Specialty Representatives gained access through appointments with “no­-see” healthcare professionals

  • Directly connected 15 patients to therapy

Related Resources

Discover how we can help patients sustain trial participation.

Learn More
White TrialCard logo

Problem-solving makes our day.

Contact us for answers.

Michael Carlin, vice president, marketing

Michael Carlin
Vice President,
Marketing
mcarlin@trialcard.com